ly3532226
Showing 1 - 3 of 3
Diabetes, Type 1 Trial in Chula Vista (LY3532226, Placebo)
Not yet recruiting
- Diabetes Mellitus, Type 1
- LY3532226
- Placebo
-
Chula Vista, CaliforniaProSciento, Inc
May 25, 2023
Diabetes, Type 2 Trial in Neuss (LY3532226, Placebo, Dulaglutide)
Recruiting
- Diabetes Mellitus, Type 2
- LY3532226
- +2 more
-
Neuss, GermanyProfil Institut für Stoffwechselforschung
Jun 30, 2022
Healthy Trial in Singapore (LY3532226, Placebo)
Completed
- Healthy
- LY3532226
- Placebo
-
Singapore, SingaporeLilly Centre for Clinical Pharmacology
Dec 16, 2021